Trial Profile
d68Ga-DOTATATE PET/CT Assessment of Cardiac Sarcoidosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Oct 2020
Price :
$35
*
At a glance
- Drugs Gallium 68-DOTATATE (Primary) ; Fludeoxyglucose F-18
- Indications Heart disorders; Sarcoidosis
- Focus Diagnostic use
- 06 Jul 2020 Status changed from recruiting to completed.
- 14 Aug 2018 Status changed from not yet recruiting to recruiting.
- 14 Jun 2018 New trial record